ARK Investment Management - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 59 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$2,082,000
+207.1%
93,143
+75.2%
0.10%
+90.7%
Q4 2017$678,000
+306.0%
53,176
+345.7%
0.05%
+63.6%
Q2 2017$167,000
+317.5%
11,932
+558.9%
0.03%
+175.0%
Q1 2017$40,0001,8110.01%
Other shareholders

There were no reported owners of JOUNCE THERAPEUTICS INC in Q1 2017.

NameSharesValueWeighting ↓
View complete list of JOUNCE THERAPEUTICS INC shareholders